Page 125 - Bioterrorism
P. 125

124


               <http://www.uptilt.com/c.html?rtr=on&s=69l,176sg,29k4,lgbj,65js,4h4n,gyv>

                Four big vax makers ready H1N1 jabs
               <http://www.uptilt.com/c.html?rtr=on&s=69l,176sg,29k4,fd0m,af61,4h4n,gyv>

                By John Carroll

               <http://www.uptilt.com/c.html?rtr=on&s=69l,176sg,29k4,b8rd,2itq,4h4n,gyv#comment>
                Comment
               <http://www.uptilt.com/c.html?rtr=on&s=69l,176sg,29k4,b8rd,2itq,4h4n,gyv#comment>
                |
               <http://www.uptilt.com/c.html?rtr=on&s=69l,176sg,29k4,3z61,km8,4h4n,gyv>
                Forward
               <http://www.uptilt.com/c.html?rtr=on&s=69l,176sg,29k4,3z61,km8,4h4n,gyv>

                Vaccine teams for four of the world's largest vaccine manufacturers
               say they have the seed stock they need to develop a new swine flu vax
               for use this autumn. But the researchers add that they're still
               uncertain just how much of the growing demand for the vaccine can be
               met.

                "It will probably take a couple of weeks to ascertain the yields
               before we get into large-scale manufacture," a Glaxo spokesman told
               Reuters. Teams for GlaxoSmithKline, Sanofi-Aventis, Novartis and
               Solvay all say they're at work on a new H1N1 jab, but they need to
               determine how well the strain they're working with will grow in a
               manufacturing setting before they can calculate yields.

                All these vaccine manufacturers could reap windfall profits from a
               burst of new orders for the new flu vaccine. Developed countries have
               already started to ink contracts. And the manufacturers will be able
               to shift from seasonal flu vaccines to the H1N1 vax as they deploy a
               new array of resources built in recent years to improve on the world's
               supply of vaccines.

                - read the report
               <http://www.uptilt.com/c.html?rtr=on&s=69l,176sg,29k4,q2f,hroq,4h4n,gyv>
                from Reuters

                Related Article:

                Novavax shares soar on NIH swine flu agreement
               <http://www.uptilt.com/c.html?rtr=on&s=69l,176sg,29k4,4wka,29cf,4h4n,gyv>

                Glaxo expects vax orders to spike as WHO outlines deadlines
               <http://www.uptilt.com/c.html?rtr=on&s=69l,176sg,29k4,fx2l,j1bc,4h4n,gyv>

                UK ordering up new flu vax stockpile
               <http://www.uptilt.com/c.html?rtr=on&s=69l,176sg,29k4,a887,g8d8,4h4n,gyv>

                Novartis readies key adjuvant for swine flu use
               <http://www.uptilt.com/c.html?rtr=on&s=69l,176sg,29k4,kl6c,dutc,4h4n,gyv>

                Read more about: Sanofi-Aventis
   120   121   122   123   124   125   126   127   128   129   130